This InspectorProfile is a report of relevant audit-related information on Meisha Sampson, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Meisha Sampson's 90 inspections in 15 countries: France, India, United States, United Kingdom, Sweden, Israel, Germany, Australia, Dominican Republic (the), Spain, Netherlands, Guyana, China, Italy, and Romania.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Meisha Sampson's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Meisha Sampson.
Note: The EIR and 483 documents are sold separately.Add To Cart24 of Meisha's 483s Available Now.